We are live on ! Find out more
ZOM

Zomedica Corp.

Delisted

ZOM was delisted on the 4th of March, 2025.

107 hedge funds and large institutions have $61.8M invested in Zomedica Corp. in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 28 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

1% more funds holding

Funds holding: 106107 (+1)

11% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 28

43% less capital invested

Capital invested by funds: $109M → $61.8M (-$46.7M)

Holders
107
Holders Change
+1
Holders Change %
+0.94%
% of All Funds
1.87%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
25
Reduced
28
Closed
16
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$21.7M -$618K -1,046,917 -2%
State Street
2
State Street
Massachusetts
$11.9M +$2.61M +4,431,423 +24%
BlackRock
3
BlackRock
New York
$9.48M +$465K +788,615 +5%
Cambridge Investment Research Advisors
4
Cambridge Investment Research Advisors
Iowa
$5.83M -$869 -1,473 -0%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$4.26M +$157K +265,719 +3%
Northern Trust
6
Northern Trust
Illinois
$1.17M +$41.8K +70,752 +3%
Swiss National Bank
7
Swiss National Bank
Switzerland
$1.07M +$36.2K +61,400 +3%
California State Teachers Retirement System (CalSTRS)
8
California State Teachers Retirement System (CalSTRS)
California
$394K +$444K +753,018 New
Citadel Advisors
9
Citadel Advisors
Florida
$357K +$402K +681,371 New
Morgan Stanley
10
Morgan Stanley
New York
$356K -$773K -1,310,393 -66%
Jane Street
11
Jane Street
New York
$342K +$361K +612,592 +1,480%
PWMG
12
Pinnacle Wealth Management Group
Michigan
$317K -$236K -400,000 -40%
CS
13
Credit Suisse
Switzerland
$301K -$566 -959 -0.2%
Goldman Sachs
14
Goldman Sachs
New York
$298K +$9.85K +16,688 +3%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$297K +$86.4K +146,366 +35%
UBS AM
16
UBS AM
Illinois
$294K
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$265K -$74.4K -126,100 -20%
Commonwealth Equity Services
18
Commonwealth Equity Services
Massachusetts
$236K +$72.7K +123,155 +37%
Victory Capital Management
19
Victory Capital Management
Texas
$227K -$1.33K -2,255 -0.5%
SSA
20
Schonfeld Strategic Advisors
New York
$209K -$117K -199,035 -33%
HF
21
HRT Financial
New York
$209K +$236K +399,494 New
Legal & General Group
22
Legal & General Group
United Kingdom
$194K +$105K +177,858 +93%
Charles Schwab
23
Charles Schwab
California
$181K
ASRS
24
Arizona State Retirement System
Arizona
$132K +$4.43K +7,508 +3%
Millennium Management
25
Millennium Management
New York
$119K -$177K -300,377 -57%

ZOM Hedge Fund Activity: Q3 2021 in Review

107 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q3 2021, worth a combined $61.8M — down 43% from $109M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new ZOM positions and 16 closed out — a net gain of 4 holders — while 25 added to existing stakes and 28 trimmed.

The largest buyer was State Street, adding an estimated $2.61M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $11.1M sold.

  • 107 institutional investors held Zomedica Corp. (ZOM) as of Q3 2021, up from 106 in Q2 2021.
  • Funds reported $61.8M of Zomedica Corp. stock for Q3 2021, down 43% quarter-over-quarter.
  • 20 funds opened new Zomedica Corp. positions in Q3 2021 and 16 closed out, a net change of +4 holders.
  • The largest Zomedica Corp. buyer in Q3 2021 was State Street, an estimated $2.61M added.
  • The largest Zomedica Corp. seller in Q3 2021 was Renaissance Technologies, an estimated $11.1M sold.

Based on aggregated 13F filings for Q3 2021.